Lantheus Holdings, Inc. Repayments of Senior Debt
Lantheus Holdings, Inc. (LNTH) reported Repayments of Senior Debt of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfSeniorDebt · last filed 2018-02-26
- Lantheus Holdings, Inc. repayments of senior debt for the quarter ending 2015-12-31 was $0.00.
- Lantheus Holdings, Inc. repayments of senior debt for the quarter ending 2015-09-30 was $0.00.
- Lantheus Holdings, Inc. repayments of senior debt for fiscal 2017 was $0.00.
- Lantheus Holdings, Inc. repayments of senior debt for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- Lantheus Holdings, Inc. repayments of senior debt for fiscal 2015 was $400.00M.
- Lantheus Holdings, Inc. repayments of senior debt for fiscal 2014 was $0.00.
| Period end | Repayments of Senior Debt 3 month | Repayments of Senior Debt 6 month | Repayments of Senior Debt 9 month | Repayments of Senior Debt 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-02-26 | |||
| 2016-12-31 | $0.00 10-K · filed 2018-02-26 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $0.00 derived: sum of 2 quarters · filed 2018-02-26 | $400.00M 10-K · filed 2018-02-26 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $400.00M 10-Q · filed 2016-11-01 | ||
| 2015-06-30 | $400.00M 10-Q · filed 2016-08-04 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |